Skip to main content
Jonathan Silberstein, MD, Urology, Aventura, FL

JonathanLSilbersteinMDMBA, FACS

Urology Aventura, FL

Surgical Oncology

Chief of Urologic Oncology, Chief of Urology, Residency Program Director, Memorial Healthcare System; Broward, Florida

Dr. Silberstein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Silberstein's full profile

Already have an account?

Education & Training

  • Tulane University School of Business
    Tulane University School of BusinessMBA, 2015 - 2018
  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Urologic Surgical Oncology, 2010 - 2013
  • University of California (San Diego) Medical Center
    University of California (San Diego) Medical CenterResidency, Urology, 2006 - 2010
  • University of California (San Diego) Medical Center
    University of California (San Diego) Medical CenterInternship, Transitional Year, 2005 - 2006
  • SUNY Upstate Medical University
    SUNY Upstate Medical UniversityClass of 2004
  • University of Pennsylvania
    University of PennsylvaniaB.A., Biology, 1995 - 1999

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2020 - 2026
  • NY State Medical License
    NY State Medical License 2010 - 2021
  • LA State Medical License
    LA State Medical License 2013 - 2021
  • CA State Medical License
    CA State Medical License 2006 - 2020
  • American Board of Urology Urology
  • Fellow American college surgeonsFACS

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2013
  • Best of Session European Association of Urologists 26th Congress, 2011
  • Abstract Winner- First Place Inaugural International Prostate Cancer Symposium, 2011
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Physical Models of Renal Malignancies Using Standard Cross-sectional Imaging and 3-Dimensional Printers: A Pilot Study.  
    Silberstein JL, Maddox MM, Dorsey P, Feibus A, Thomas R, Lee BR., Urology, 6/21/2014
  • Clinical Outcomes for Local and Metastatic Testicular Sex Cord-Stromal Tumors  
    Silberstein JL, Bazzi WM, Vertosick E, Carver BS, Bosl GJ, Feldman DR, Bajorin DF, Motzer RJ, Al-Ahmadie H, Reuter VE, Shienfeld J, J Urology, 2/8/2014
  • Current Clinical Challenges in Prostate Cancer  
    Silberstein JL, Pal SP, Lewis B, Sartor O, Translational Andrology and Urology, 9/1/2013
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Use of Vacuum-assisted device for Fournier's gangrene: a new paradigm (Moderated Poster Presentation)
    Silberstein J, Grabowski J, Parsons JK, Annual Meeting of the American Urologic Association, Orlando, FL, 5/1/2008

Lectures

  • Physical models of renal malignancies using standard cross-sectional imaging and three-dimensional printers: A pilot study 
    4/1/2014
  • Radical Prostatectomy for High Risk Prostate Cancer 
    4/1/2014
  • Genitourinary Malignancy Before, During and After Renal Transplantation 
    3/1/2014
  • Join now to see all

Other

  • Beyond the Abstract - Reverse stage shift at a tertiary care center: Escalating risk in men undergoing radical prostatectomy 
    Laudone VP, Silberstein JL, Urotoday.com
    9/1/2011

Press Mentions

  • New Technology Leads to More Accurate Prostate Cancer Diagnosis and Treatments
    New Technology Leads to More Accurate Prostate Cancer Diagnosis and TreatmentsMay 24th, 2021
  • Med Students Are Getting Terrible Training in Robotic Surgery
    Med Students Are Getting Terrible Training in Robotic SurgeryMarch 15th, 2018
  • PSA, PSAD Less Predictive of Aggressive PCa in Black Men
    PSA, PSAD Less Predictive of Aggressive PCa in Black MenFebruary 17th, 2017
  • Join now to see all